Drug Shortage Report for TARO-ATENOLOL
| Report ID | 12326 |
| Drug Identification Number | 02267985 |
| Brand name | RAN-ATENOLOL |
| Common or Proper name | RAN-ATENOLOL |
| Company Name | SUN PHARMA CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ATENOLOL |
| Strength(s) | 50MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | C07AB |
| ATC description | BETA BLOCKING AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2017-01-01 |
| Actual start date | 2017-08-06 |
| Estimated end date | 2018-05-31 |
| Actual end date | 2017-07-14 |
| Shortage status | Avoided shortage |
| Updated date | 2019-02-04 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2017-06-08 | English | Compare |